Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
95,975,362
-
Share change
-
+1,238,456
-
Total reported value
-
$5,879,197,865
-
Put/Call ratio
-
62%
-
Price per share
-
$61.28
-
Number of holders
-
219
-
Value change
-
+$103,868,412
-
Number of buys
-
126
-
Number of sells
-
78
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q3 2017
As of 30 Sep 2017 NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) had 219 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 95,975,362 shares of stock of the company.
Largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, BB BIOTECH AG, FRANKLIN RESOURCES INC, and Invesco Ltd..
This table shows 220 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.